196
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

Everolimus maintenance in patients with mantle cell lymphoma not eligible for intensive therapy: results of a prematurely closed phase 2 study

, , , , , & show all
Pages 3227-3229 | Received 02 Feb 2015, Accepted 04 Mar 2015, Published online: 31 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Pavel Klener. (2020) Mantle cell lymphoma: insights into therapeutic targets at the preclinical level. Expert Opinion on Therapeutic Targets 24:10, pages 1029-1045.
Read now
Madeliene Parrott & Simon Rule. (2018) Does maintenance therapy have a role in mantle cell lymphoma treatment?. Expert Review of Hematology 11:4, pages 285-292.
Read now

Articles from other publishers (3)

Tingxun Lu, Jie Zhang, Jenna M. McCracken & Ken H. Young. (2024) Recent advances in genomics and therapeutics in mantle cell lymphoma. Cancer Treatment Reviews 122, pages 102651.
Crossref
Inhye E. Ahn, Jennifer R. Brown, and & Matthew S. Davids. 2023. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies 71 85 .
Chan Yoon CheahJohn F. SeymourMichael L. Wang. (2016) Mantle Cell Lymphoma. Journal of Clinical Oncology 34:11, pages 1256-1269.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.